Display On Homepage:
Display on Home Page
Comment Snippet:
<p>
Most clinical research on an active ingredient is done under time constraint due to the high cost of clinical research. Thus, researchers often use high doses to achieve a measurable outcome. It is not necessarily advisable to consume long-term the dose used in a short-term clinical trial. A smaller dose may very well not only be advisable from an efficacy point of view, but also from a safety point of view. Olav E. Sandnes, President, Marine Ingredients</p>
